A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia
Clinical trial NCT00645515 · TERMINATED
Trial details
- NCT number
- NCT00645515
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.